Vancouver, British Columbia – TheNewswire - January 21, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company that conducts clinical health research and has developed a world first AI prediction tool for drug and alcohol intoxication detection using voice, is pleased to announce the Company has listed its common shares for trading on the OTCQB Market.The Company’s listing of its common shares for trading on the OTCQB Market comes ...